Mrs. Alvatina L Davis, LPN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 14 Red Top Ln, Palm Coast, FL 32164 Phone: 386-569-7991 Fax: 386-263-8131 |
News Archive
"Estimates suggest that by 2040, over nine million people with HIV will be 50 or older in sub-Saharan Africa, triple that of current data," The Body reports, noting, "Despite this, the 2012 UNAIDS report does not mention the aging of HIV," and "because it does not include data on those aged 50 or older, the report is inaccurate and misleading."
Tolero Pharmaceuticals, Inc., a late clinical-stage biopharmaceutical company developing treatments for oncology and blood disorders, reported positive interim results from an ongoing, randomized Phase 2 clinical trial of its lead drug candidate, alvocidib, in combination with cytarabine plus mitoxantrone for previously untreated acute myeloid leukemia (AML) patients.
According to a recent study in the Archives of Internal Medicine, 75 percent of Americans do not get enough Vitamin D.
Huifeng Bio-Pharmaceutical Technology, Inc., specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announces a definitive agreement under which Huifeng will acquire 90% of the equity ownership of Shangqiu Kexin Rutin Processing Ltd., a local leading Rutin manufacturer in Henan Province, at a price of $1.75 million. As a result of the acquisition, Kexin will be a wholly-owned subsidiary of Huifeng.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago